Study_Author,PMID,Year,Age,Older_women,UI_type,followup,n1,n2,N1,N2,granular_trt_code1,granular_trt_code2,coarse_trt_code1,coarse_trt_code2,trt_description1,trt_description2,OR12,OR21,Outcome,combined,Randomization_Sequence,Blinding_of_Patients,Blinding_of_Assessors,Intention_to_Treat,Attrition_Bias,Selection_Bias,Interventions_Described,Intervention_Compliance,Other_Issues,Allocation_Concealment
Golmakani,24498480,2014,45.5,0,stress,3,2,3,26,25,T1,T4+T9,T,T,bladder training,"pfmt (pelvic floor muscle therapy), weights",0.611111111,1.636363636,ui,Golmakani 2014 24498480,Low RoB,High RoB,Low RoB,High RoB,High RoB (Loss to f/up due to intervention-specific reasons; 15% overall),Low RoB,Yes,High RoB (Loss to f/up due to non-adherence (4/60)),No,High RoB
Amundsen,27701661,2016,63,0,urge,6,64,68,190,174,B1,N2,B,N,botox,interstim,0.79178338,1.262971698,ui,Amundsen 2016 27701661,Low RoB,High RoB,High RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Amundsen,27701661,2016,63,0,urge,6,113,89,190,174,B1,N2,B,N,botox,interstim,1.401575952,0.713482561,satisfaction,Amundsen 2016 27701661,Low RoB,High RoB,High RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Amundsen,27701661,2016,63,0,urge,6,26,2,127,99,B1,N2,B,N,botox,interstim,12.48514851,0.080095163,cure,Amundsen 2016 27701661,Low RoB,High RoB,High RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Amundsen,27701661,2016,63,0,urge,6,63,27,127,99,B1,N2,B,N,botox,interstim,2.625,0.380952381,improvement,Amundsen 2016 27701661,Low RoB,High RoB,High RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Kafri,23160873,2013,56.7,0,urge,48,11,6,35,24,T1,C3,T,C,bladder training,tolterodine,1.375,0.727272727,cure,Kafri 2013 23160873,Low RoB,High RoB (Patients we not blinded),Low RoB,Low RoB,High RoB (much higher dropout rate in the drug arm than any other (36%)),Low RoB,Yes,High RoB (adherence to drug = 64%; others 85-95%),No,Low RoB
Kafri,23160873,2013,56.7,0,urge,48,24,6,59,24,T4,C3,T,C,pfmt (pelvic floor muscle therapy),tolterodine,2.057142857,0.486111111,cure,Kafri 2013 23160873,Low RoB,High RoB (Patients we not blinded),Low RoB,Low RoB,High RoB (much higher dropout rate in the drug arm than any other (36%)),Low RoB,Yes,High RoB (adherence to drug = 64%; others 85-95%),No,Low RoB
Kafri,23160873,2013,56.7,0,urge,48,11,24,35,59,T1,T4,T,T,bladder training,pfmt (pelvic floor muscle therapy),0.668402778,1.496103896,cure,Kafri 2013 23160873,Low RoB,High RoB (Patients we not blinded),Low RoB,Low RoB,High RoB (much higher dropout rate in the drug arm than any other (36%)),Low RoB,Yes,High RoB (adherence to drug = 64%; others 85-95%),No,Low RoB
Visco,23036134,2012,58,0,urge,6,26,13,112,119,B1,C2,B,C,botox,solifenacin,2.465116279,0.405660377,cure,Visco 2012 23036134,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Unclear RoB (not reported)
Visco,23036134,2012,58,0,urge,6,61,48,112,119,B1,C2,B,C,botox,solifenacin,1.769199346,0.56522743,improvement,Visco 2012 23036134,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Unclear RoB (not reported)
Gittelman,24231837,2014,57,0,0,3,24,15,96,112,C1,P1,C,P,oxybutynin,control,2.155555556,0.463917526,cure,Gittelman 2014 24231837,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Sokol,24704117,2014,58.5,0,0,12,48,105,116,229,U2,U1,U,U,contigen,bulkamide,0.833613445,1.199596774,improvement,Sokol 2014 24704117,Low RoB,Low RoB,Unclear RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Unclear RoB
Sokol,24704117,2014,58.5,0,0,12,22,44,90,183,U2,U1,U,U,contigen,bulkamide,1.022058824,0.978417266,cure,Sokol 2014 24704117,Low RoB,Low RoB,Unclear RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Unclear RoB
Wiegersma,25533442,2014,64.25,1,0,3,70,10,115,124,T4,P1,T,P,pfmt (pelvic floor muscle therapy),control,17.73333333,0.056390977,improvement,Wiegersma 2014 25533442,Low RoB,Low RoB,Unclear RoB,Low RoB,High RoB,Low RoB,Yes,Low RoB,No,Low RoB
Capobianco,21706345,2012,57.8,1,stress,6,93,22,103,103,H1,H1+N4+T4,H,H+N+T,vaginal estrogen,"vaginal estrogen, pfmt, tens",34.24090909,0.029204832,ui,Capobianco 2012 21706345,Low RoB,High RoB,High RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Capobianco,21706345,2012,57.8,1,stress,6,10,61,103,83,H1,H1+N4+T4,H,H+N+T,vaginal estrogen,"vaginal estrogen, pfmt, tens",0.038780187,25.78636364,improvement,Capobianco 2012 21706345,Low RoB,High RoB,High RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Rovner,23796570,2013,52.6,0,stress,6,43,15,66,49,V1,P1,V,P,intravessical pressure release,control,4.237681159,0.235978112,improvement,Rovner 2013 23796570,Low RoB,Low RoB,Low RoB,High RoB (11% dropout for device or proceedure issue. Not included in analysis),High RoB (differential dropout),Low RoB,Yes,Low RoB,No,Low RoB
Rovner,23796570,2013,52.6,0,stress,6,22,8,66,49,V1,P1,V,P,intravessical pressure release,control,2.5625,0.390243902,cure,Rovner 2013 23796570,Low RoB,Low RoB,Low RoB,High RoB (11% dropout for device or proceedure issue. Not included in analysis),High RoB (differential dropout),Low RoB,Yes,Low RoB,No,Low RoB
Kim,21545385,2011,76,1,0,3,1,12,34,35,T2,T4,T,T,education,pfmt (pelvic floor muscle therapy),0.058080808,17.2173913,cure,Kim 2011 21545385,Low RoB,Low RoB,High RoB,High RoB (2 drop outs in the intervention arm were potentially treatment related),Low RoB,Low RoB,Yes,Low RoB (mean attendance at classes = 70%),No,Low RoB
Kim,21545385,2011,76,1,0,3,1,19,34,37,T2,T3+T4,T,T,education,"heat therapy, pfmt",0.028708134,34.83333333,cure,Kim 2011 21545385,Low RoB,Low RoB,High RoB,High RoB (2 drop outs in the intervention arm were potentially treatment related),Low RoB,Low RoB,Yes,Low RoB (mean attendance at classes = 70%),No,Low RoB
Kim,21545385,2011,76,1,0,3,1,8,34,37,T2,T3,T,T,education,heat therapy,0.109848485,9.103448276,cure,Kim 2011 21545385,Low RoB,Low RoB,High RoB,High RoB (2 drop outs in the intervention arm were potentially treatment related),Low RoB,Low RoB,Yes,Low RoB (mean attendance at classes = 70%),No,Low RoB
Kim,21545385,2011,76,1,0,3,12,19,35,37,T4,T3+T4,T,T,pfmt (pelvic floor muscle therapy),"heat therapy, pfmt",0.494279176,2.023148148,cure,Kim 2011 21545385,Low RoB,Low RoB,High RoB,High RoB (2 drop outs in the intervention arm were potentially treatment related),Low RoB,Low RoB,Yes,Low RoB (mean attendance at classes = 70%),No,Low RoB
Kim,21545385,2011,76,1,0,3,12,8,35,37,T4,T3,T,T,pfmt (pelvic floor muscle therapy),heat therapy,1.891304348,0.528735632,cure,Kim 2011 21545385,Low RoB,Low RoB,High RoB,High RoB (2 drop outs in the intervention arm were potentially treatment related),Low RoB,Low RoB,Yes,Low RoB (mean attendance at classes = 70%),No,Low RoB
Kim,21545385,2011,76,1,0,3,19,8,37,37,T3+T4,T3,T,T,"heat therapy, pfmt",heat therapy,3.826388889,0.261343013,cure,Kim 2011 21545385,Low RoB,Low RoB,High RoB,High RoB (2 drop outs in the intervention arm were potentially treatment related),Low RoB,Low RoB,Yes,Low RoB (mean attendance at classes = 70%),No,Low RoB
Oldham,23023996,2013,48.1,0,0,3,32,40,49,46,T4,N4+T4,T,N+T,pfmt (pelvic floor muscle therapy),"tens, pfmt",0.282352941,3.541666667,improvement,Oldham 2013 23023996,Low RoB,High RoB,Low RoB,Unclear RoB (reasons for dropouts not given),High RoB (20% drop out),Low RoB,Yes,Low RoB,No,Unclear RoB (not reported)
Kaya,25266357,2015,48.7,0,0,1.5,40,33,56,52,T1,T1+T4,T,T,bladder training,"bladder training, pfmt",1.439393939,0.694736842,improvement,Kaya 2015 25266357,Low RoB,High RoB,High RoB,Low RoB,High RoB,Low RoB,Yes,Low RoB,No,High RoB
Kaya,25266357,2015,48.7,0,0,1.5,3,23,56,52,T1,T1+T4,T,T,bladder training,"bladder training, pfmt",0.071369975,14.01149425,cure,Kaya 2015 25266357,Low RoB,High RoB,High RoB,Low RoB,High RoB,Low RoB,Yes,Low RoB,No,High RoB
Lim,27871927,2017,45.6,0,stress,2,19,3,60,60,N3,P1,N,P,magnetic stimulation,control,8.804878049,0.113573407,cure,Lim 2017 27871927,Low RoB,Low RoB,Unclear RoB,Low RoB,Low RoB,Unclear RoB,Yes,Low RoB,No,Unclear RoB
Lim,27871927,2017,45.6,0,stress,2,47,27,57,58,N3,P1,N,P,magnetic stimulation,control,5.396296296,0.185312286,satisfaction,Lim 2017 27871927,Low RoB,Low RoB,Unclear RoB,Low RoB,Low RoB,Unclear RoB,Yes,Low RoB,No,Unclear RoB
Lim,27871927,2017,45.6,0,stress,2,45,13,60,60,N3,P1,N,P,magnetic stimulation,control,10.84615385,0.092198582,improvement,Lim 2017 27871927,Low RoB,Low RoB,Unclear RoB,Low RoB,Low RoB,Unclear RoB,Yes,Low RoB,No,Unclear RoB
Rovner,21351127,2011,58.8,0,urge,3,27,7,53,44,B1,P1,B,P,botox,control,5.489010989,0.182182182,cure,Rovner 2011 21351127,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
McMichael,no pmid,2013,54.4,0,urge,1,20,21,33,34,P1,C3,P,C,control,tolterodine,0.952380952,1.05,improvement,McMichael 2013 no pmid,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Unclear RoB (very few baselines given),No (dosage not given in mg),Unclear RoB (not reported),No,Unclear RoB (not reported)
Dede,23086134,2013,51.83,0,0,1.5,2,3,30,30,C1,C4,C,C,oxybutynin,trospium,0.642857143,1.555555556,cure,Dede 2013 23086134,Low RoB,unclear,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Dede,23086134,2013,51.83,0,0,1.5,7,3,30,30,C3,C4,C,C,tolterodine,trospium,2.739130435,0.365079365,cure,Dede 2013 23086134,Low RoB,unclear,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Dede,23086134,2013,51.83,0,0,1.5,2,7,30,30,C1,C3,C,C,oxybutynin,tolterodine,0.234693878,4.260869565,cure,Dede 2013 23086134,Low RoB,unclear,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Dede,23086134,2013,51.83,0,0,1.5,22,17,30,30,C1,C4,C,C,oxybutynin,trospium,2.102941176,0.475524476,improvement,Dede 2013 23086134,Low RoB,unclear,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Dede,23086134,2013,51.83,0,0,1.5,19,17,30,30,C3,C4,C,C,tolterodine,trospium,1.320855615,0.75708502,improvement,Dede 2013 23086134,Low RoB,unclear,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Dede,23086134,2013,51.83,0,0,1.5,22,19,30,30,C1,C3,C,C,oxybutynin,tolterodine,1.592105263,0.628099174,improvement,Dede 2013 23086134,Low RoB,unclear,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Samuelsson,no pmid,2017,44.7,0,stress,3,56,12,62,61,T4,P1,T,P,pfmt (pelvic floor muscle therapy),control,38.11111111,0.026239067,improvement,Samuelsson 2017 no pmid,Low RoB,High RoB,High RoB,Low RoB,Low RoB,Low RoB,Yes,Unclear RoB (not reported),No,Unclear RoB (not reported)
Jabs,23343798,2013,63.4,0,urge,6,6,0,11,10,B1,P1,B,P,botox,control,24.81818182,0.04029304,cure,Jabs 2013 23343798,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Wang,28153510,2017,NA,0,urge,0.75,34,1,80,40,N1,N4,N,N,electroacupuncture,tens (transcutaneous electrical nerve stimulation),28.82608696,0.034690799,cure,Wang 2017 28153510,Low RoB,High RoB,Unclear RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Wang,28153510,2017,NA,0,urge,0.75,56,18,80,40,N1,N4,N,N,electroacupuncture,tens (transcutaneous electrical nerve stimulation),2.851851852,0.350649351,improvement,Wang 2017 28153510,Low RoB,High RoB,Unclear RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Xu,26960195,2016,58.5,0,stress,1.5,39,23,40,40,N1,P1,N,P,electroacupuncture,control,28.82608696,0.034690799,satisfaction,Xu 2016 26960195,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Sherburn,21284022,2011,71.8,1,stress,5,6,14,35,41,T1,T4,T,T,bladder training,pfmt (pelvic floor muscle therapy),0.399014778,2.50617284,improvement,Sherburn 2011 21284022,Low RoB,High RoB,Low RoB,High RoB (completers only assessed),Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Sherburn,21284022,2011,71.8,1,stress,5,15,26,35,43,T1,T4,T,T,bladder training,pfmt (pelvic floor muscle therapy),0.490384615,2.039215686,satisfaction,Sherburn 2011 21284022,Low RoB,High RoB,Low RoB,High RoB (completers only assessed),Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Abdulaziz,no pmid,2012,43.8,0,stress,3,5,26,27,29,P1,T4,P,T,control,pfmt (pelvic floor muscle therapy),0.026223776,38.13333333,cure,Abdulaziz 2012 no pmid,Low RoB,High RoB,High RoB,Low RoB,Low RoB,Unclear RoB (very few baselines given),Yes,"Unclear RoB (""Some women who missed their sessions were requested for compliance in future."")",No,Unclear RoB (not reported)
Abdulaziz,no pmid,2012,43.8,0,stress,3,0,0,27,29,P1,T4,P,T,control,pfmt (pelvic floor muscle therapy),1.072727273,0.93220339,ui,Abdulaziz 2012 no pmid,Low RoB,High RoB,High RoB,Low RoB,Low RoB,Unclear RoB (very few baselines given),Yes,"Unclear RoB (""Some women who missed their sessions were requested for compliance in future."")",No,Unclear RoB (not reported)
Ozlu,28345778,2017,42.4,0,stress,2,8,28,17,34,T4,T4+T6,T,T,pfmt (pelvic floor muscle therapy),"pfmt (pelvic floor muscle therapy), biofeedback",0.19047619,5.25,improvement,Ozlu 2017 28345778,Low RoB,High RoB,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Unclear RoB (not reported)
Ozlu,28345778,2017,42.4,0,stress,2,7,28,17,34,T4,T4+T6,T,T,pfmt (pelvic floor muscle therapy),"pfmt (pelvic floor muscle therapy), biofeedback",0.15,6.666666667,satisfaction,Ozlu 2017 28345778,Low RoB,High RoB,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Unclear RoB (not reported)
Terlikowski,23443345,2013,46.9,0,stress,4,2,29,29,64,P1,N4+T6,P,N+T,control,"tens (transcutaneous electrical nerve stimulation), biofeedback",0.089399745,11.18571429,cure,Terlikowski 2013 23443345,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Terlikowski,23443345,2013,46.9,0,stress,4,4,12,29,64,P1,N4+T6,P,N+T,control,"tens (transcutaneous electrical nerve stimulation), biofeedback",0.693333333,1.442307692,improvement,Terlikowski 2013 23443345,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Porta-Roda,25130167,2015,NA,0,0,6,21,32,30,35,T4,T4+T9,T,T,pfmt (pelvic floor muscle therapy),"pfmt (pelvic floor muscle therapy), weights",0.21875,4.571428571,improvement,Porta-Roda 2015 25130167,Low RoB,High RoB,High RoB,Low RoB,Low RoB,Low RoB,Yes,High RoB (compliance was <70% at beginning and <50% at end of study),No,Low RoB
Ong,26142713,2015,51.9,0,stress,4,10,12,16,21,T4,T4+T6,T,T,pfmt (pelvic floor muscle therapy),"pfmt (pelvic floor muscle therapy), biofeedback",1.25,0.8,cure,Ong 2015 26142713,Low RoB,High RoB,Unclear RoB,High RoB (dropouts not analyzed),Low RoB,Low RoB,Yes,Low RoB,"Yes (Potentially a typo, but results for certain outcomes report more dropouts than participant flow)",Unclear RoB (concealment not described)
Ong,26142713,2015,51.9,0,stress,4,13,13,16,16,T4,T4+T6,T,T,pfmt (pelvic floor muscle therapy),"pfmt (pelvic floor muscle therapy), biofeedback",1,1,improvement,Ong 2015 26142713,Low RoB,High RoB,Unclear RoB,High RoB (dropouts not analyzed),Low RoB,Low RoB,Yes,Low RoB,"Yes (Potentially a typo, but results for certain outcomes report more dropouts than participant flow)",Unclear RoB (concealment not described)
Lian,26054138,2015,51.5,0,stress,NA,10,15,45,45,A2,N4,A,N,midodrine,tens (transcutaneous electrical nerve stimulation),0.571428571,1.75,cure,Lian 2015 26054138,Unclear RoB,High RoB,Unclear RoB,Unclear RoB,Low RoB,Unclear RoB,Yes,Unclear RoB,No,Unclear RoB
Lian,26054138,2015,51.5,0,stress,NA,21,24,45,45,A2,N4,A,N,midodrine,tens (transcutaneous electrical nerve stimulation),0.765625,1.306122449,improvement,Lian 2015 26054138,Unclear RoB,High RoB,Unclear RoB,Unclear RoB,Low RoB,Unclear RoB,Yes,Unclear RoB,No,Unclear RoB
Rutledge,24183730,2014,57,0,0,3,8,16,20,20,P1,T4,P,T,control,pfmt (pelvic floor muscle therapy),0.166666667,6,improvement,Rutledge 2014 24183730,Low RoB,High RoB,High RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Wang,26921645,2016,56.9,0,stress,4,11,3,21,21,N1,N4+T4,N,N+T,electroacupuncture,"tens, pfmt",6.6,0.151515152,cure,Wang 2016 26921645,Unclear RoB,High RoB,Unclear RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Unclear RoB
Wang,26921645,2016,56.9,0,stress,4,5,2,21,21,N1,N4+T4,N,N+T,electroacupuncture,"tens, pfmt",2.96875,0.336842105,improvement,Wang 2016 26921645,Unclear RoB,High RoB,Unclear RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Unclear RoB
Tannenbaum,24334159,2013,71.6,1,0,3,111,7,195,64,T2,P1,T,P,education,control,10.76020408,0.09293504,improvement,Tannenbaum 2013 24334159,Low RoB,High RoB,High RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Unclear RoB (not reported)
Lopès,25444700,2014,51.24,0,stress,6,63,58,76,85,N4,P1,N,P,tens (transcutaneous electrical nerve stimulation),control,2.25596817,0.443268665,improvement,Lopès 2014 25444700,Low RoB,Low RoB,Unclear RoB,Low RoB (2/163 drop-outs),Low RoB,High RoB (IMC and ICIQ score significantly differed between groups at baseline.),Yes,Unclear RoB,No,Unclear RoB
Baker,24763155,2014,58,0,urge,2,6,0,13,11,T7,T8,T,T,mbsr (mindfulness based stress reduction),yoga,19.93333333,0.050167224,improvement,Baker 2014 24763155,Low RoB,High RoB,Low RoB,Low RoB,Unclear RoB,Low RoB,Yes,Unclear RoB,No,Low RoB
Hirakawa,23306768,2013,56.8,0,stress,3,17,16,23,23,T4,T4+T6,T,T,pfmt (pelvic floor muscle therapy),"pfmt (pelvic floor muscle therapy), biofeedback",1.239583333,0.806722689,improvement,Hirakawa 2013 23306768,Low RoB,High RoB (unblinded),High RoB (unblinded assessors),Low RoB,Low RoB,Low RoB,Yes,High RoB (Dropouts due to intervention components),No,Low RoB
Liu,28655016,2017,55.4,0,stress,1.5,52,159,240,246,P1,N1,P,N,control,electroacupuncture,0.151344841,6.607427056,improvement,Liu 2017 28655016,low,low,low,low,low,low,yes,low,,low
Liu,28655016,2017,55.4,0,stress,1.5,75,210,252,252,P1,N1,P,N,control,electroacupuncture,0.084745763,11.8,satisfaction,Liu 2017 28655016,low,low,low,low,low,low,yes,low,,low
Huang,24763156,2014,61.4,0,0,1.5,9,0,9,9,T8,P1,T,P,yoga,control,361,0.002770083,satisfaction,Huang 2014 24763156,Low RoB,High RoB,Low RoB,High RoB (only completers above certain threshold analyzed),Low RoB,Low RoB,Yes,Low RoB,No,High RoB
Manonai,25920290,2015,47.8,0,stress,4,25,20,32,29,T4,T4+T6,T,T,pfmt (pelvic floor muscle therapy),"pfmt (pelvic floor muscle therapy), biofeedback",1.607142857,0.622222222,improvement,Manonai 2015 25920290,Low RoB,High RoB,Low RoB,Low RoB (Baseline observations carried forward for dropouts),Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Oreskovic,22816227,2012,56.9,0,urge,3,68,71,80,77,P1,C2,P,C,control,solifenacin,0.478873239,2.088235294,improvement,Oreskovic 2012 22816227,Low RoB,Low RoB,High RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Talley,2824818,2017,84.9,1,0,3,13,3,23,19,T1+T2+T4,P1,T,P,"pmft (pelvic floor muscle therapy), bladder training,  education",control,6.933333333,0.144230769,improvement,Talley 2017 2824818,Low RoB,High RoB (patients were not blinded),Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Talley,2824818,2017,84.9,1,0,3,19,7,23,19,T1+T2+T4,P1,T,P,"pmft (pelvic floor muscle therapy), bladder training,  education",control,8.142857143,0.122807018,satisfaction,Talley 2017 2824818,Low RoB,High RoB (patients were not blinded),Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Lovatsis,27438055,2017,51,0,stress,NA,4,12,18,18,P1,T1,P,T,control,bladder training,0.142857143,7,improvement,Lovatsis 2017 27438055,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Lovatsis,27438055,2017,51,0,stress,NA,2,9,17,14,P1,T1,P,T,control,bladder training,0.074074074,13.5,cure,Lovatsis 2017 27438055,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Low RoB,Yes,Low RoB,No,Low RoB
Hahn,10.1002/nau.1930100604,1991,47.2,0,stress,NA,1,1,10,10,N4,T4,N,T,tens,pfmt,1,1,cure,Hahn 1991 10.1002/nau.1930100604,unclear,Unclear,unclear,low,low,low,yes,low,,Unclear
Hahn,10.1002/nau.1930100604,1991,47.2,0,stress,NA,3,4,10,10,N4,T4,N,T,tens,pfmt,0.642857143,1.555555556,improvement,Hahn 1991 10.1002/nau.1930100604,unclear,Unclear,unclear,low,low,low,yes,low,,Unclear
Bo,10024253,1999,49.5,0,stress,6,3,1,32,32,N4,P1,N,P,tens,control,3.206896552,0.311827957,cure,Bo 1999 10024253,low,high,low,low,low,low,yes,low,,low
Bo,10024253,1999,49.5,0,stress,6,2,1,29,32,T4+T6,P1,T,P,pfmt & biofeedback,control,2.296296296,0.435483871,cure,Bo 1999 10024253,low,high,low,low,low,low,yes,low,,low
Bo,10024253,1999,49.5,0,stress,6,3,2,32,29,N4,T4+T6,N,T,tens,pfmt & biofeedback,1.396551724,0.716049383,cure,Bo 1999 10024253,low,high,low,low,low,low,yes,low,,low
Jackson,10428529,1999,63,0,stress,6,0,0,26,23,H2,P1,H,P,po estrogen,control,0.886792453,1.127659574,improvement,Jackson 1999 10428529,low,low,low,low,low,low,yes,low,,low
Lose,10955437,2000,66,0,0,NA,42,41,134,117,H1,H1+T5,H,H+T,vaginal estrogen,vaginal estrogen & bladder support,0.846235419,1.181704261,cure,Lose 2000 10955437,Adequate,open-label,,,,,,,,Unclear
Fujishiro,10992380,2000,58,0,stress,NA,4,1,31,31,N3,P1,N,P,magnetic stimulation,control,4.444444444,0.225,cure,Fujishiro 2000 10992380,low,low,low,low,low,unclear,yes,low,,Unclear
Fujishiro,10992380,2000,58,0,stress,NA,23,10,31,31,N3,P1,N,P,magnetic stimulation,control,6.0375,0.16563147,improvement,Fujishiro 2000 10992380,low,low,low,low,low,unclear,yes,low,,Unclear
McFall,11010699,2000,75,1,0,NA,25,15,72,73,T1+T4,P1,T,P,bladder training & pfmt,control,2.056737589,0.486206897,cure,McFall 2000 11010699,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
McFall,11067699,2000,75,1,0,NA,39,56,72,73,T1+T4,P1,T,P,bladder training & pfmt,control,0.358766234,2.787330317,ui,McFall 2000 11067699,Unclear,Unclear,Unclear,high,high (high attrition),low,yes,low,,Unclear
Lee,11125386,2001,57,0,stress,12,6,6,35,33,U3,P1,U,P,autologous fat,control,0.931034483,1.074074074,cure,Lee 2001 11125386,Low,Low,high,low,low,low,yes,low,,Unclear
Kim,11251875,2001,53.5,0,0,3,6,2,16,17,T4,P1,T,P,pfmt,control,4.5,0.222222222,cure,Kim 2001 11251875,unclear,Unclear,unclear,low,low,low,yes,high (differential between groups),,Unclear
Ishiko,11304861,2001,NA,1,stress,NA,25,23,32,34,H1+T4,T4,H+T,T,vaginal estrogen & pfmt,pfmt,1.708074534,0.585454545,cure,Ishiko 2001 11304861,low,high,high,low,low,low,yes,low,,Unclear
Pages,11421517,2001,51.1,0,stress,NA,9,20,13,27,T4+T6,T4,T,T,pfmt & biofeedback,pfmt,0.7875,1.26984127,improvement,Pages 2001 11421517,low,unclear,unclear,low,low,unclear (no baselines given),yes,low,,unclear
Pages,11421517,2001,51.1,0,stress,NA,4,6,13,27,T4+T6,T4,T,T,pfmt & biofeedback,pfmt,1.555555556,0.642857143,cure,Pages 2001 11421517,low,unclear,unclear,low,low,unclear (no baselines given),yes,low,,unclear
Lightner,11445471,2001,57.4,0,stress,12,76,79,176,188,U4,U2,U,U,durasphere,contigen,1.048607595,0.953645582,improvement,Lightner 2001 11445471,Unclear,low,low,Unclear,high (high attrition),Unclear,yes,unclear,,Unclear
Arvonen,11574936,2001,48,0,stress,4,7,11,18,19,T4+T9,T4,T,T,pfmt & weights,pfmt,0.462809917,2.160714286,improvement,Arvonen 2001 11574936,unclear,Unclear,unclear,low,low,low,yes,low,,Unclear
Arvonen,11574936,2001,48,0,stress,4,9,5,18,19,T4+T9,T4,T,T,pfmt & weights,pfmt,2.8,0.357142857,cure,Arvonen 2001 11574936,unclear,Unclear,unclear,low,low,low,yes,low,,Unclear
Subak,12100806,2002,69.3,1,0,NA,39,11,77,75,T4,P1,T,P,pfmt,control,5.971291866,0.167467949,improvement,Subak 2002 12100806,low,Unclear,high,"high (per protocol analysis, 18% dropout)",low,low,yes,low,,low
Norton,12114886,2002,51,0,stress,NA,123,132,140,138,A1,P1,A,P,duloxetine,control,0.328877005,3.040650407,cure,Norton 2002 12114886,low,low,low,low,low,low,yes,high (differed between groups),,low
Morkved,12383542,2002,46.4,0,stress,NA,28,21,48,46,T4+T6,T4,T,T,pfmt & biofeedback,pfmt,1.666666667,0.6,cure,Morkved 2002 12383542,low,high,low,low,low,low,yes,low,,low
Burgio,12425706,2002,65.4,1,urge,2,15,11,74,75,T4,T4,T,T,pfmt,pfmt,1.479198767,0.676041667,cure,Burgio 2002 12425706,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Burgio,12425706,2002,65.4,1,urge,2,15,11,73,75,T4+T6,T4,T,T,pfmt & biofeedback,pfmt,1.504702194,0.664583333,cure,Burgio 2002 12425706,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Burgio,12425706,2002,65.4,1,urge,2,15,15,74,73,T4,T4+T6,T,T,pfmt,pfmt & biofeedback,0.983050847,1.017241379,cure,Burgio 2002 12425706,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Burgio,12425706,2002,65.4,1,urge,2,36,20,74,75,T4,T4,T,T,pfmt,pfmt,2.605263158,0.383838384,improvement,Burgio 2002 12425706,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Burgio,12425706,2002,65.4,1,urge,2,33,20,73,75,T4+T6,T4,T,T,pfmt & biofeedback,pfmt,2.26875,0.44077135,improvement,Burgio 2002 12425706,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Burgio,12425706,2002,65.4,1,urge,2,36,33,74,73,T4,T4+T6,T,T,pfmt,pfmt & biofeedback,1.148325359,0.870833333,improvement,Burgio 2002 12425706,low,Unclear,unclear,low,low,low,yes,low,,Unclear
But,12639647,2003,55.8,0,0,NA,7,1,30,22,N3,P1,N,P,magnetic stimulation,control,6.391304348,0.156462585,improvement,But 2003 12639647,low,low,low,low,low,low,yes,low,,low
But,12639647,2003,55.8,0,0,NA,12,0,30,22,N3,P1,N,P,magnetic stimulation,control,30.40540541,0.032888889,cure,But 2003 12639647,low,low,low,low,low,low,yes,low,,low
Alewijnse,12808702,2003,55.6,0,0,NA,21,17,51,52,T1+T4,T4,T,T,bladder training & pfmt,pfmt,1.441176471,0.693877551,cure,Alewijnse 2003 12808702,unclear RoB,unclear,high,low,low,"high (women in control group used heabier pads and greater frequency of wet episodes than intervention groups, women in one intervention group experienced more sx distress and impact)",yes,low,,unclear
Moore,12842055,2003,60,0,0,3,37,27,74,71,T1,T1+T4,T,T,bladder training,bladder training & pfmt,1.62962963,0.613636364,cure,Moore 2003 12842055,low,low,low,low,high (high attrition),low,yes,low,,low
Goode,12865375,2003,56.2,0,0,NA,11,10,66,67,T4+T6,T2,T,T,pfmt & biofeedback,education,1.14,0.877192982,cure,Goode 2003 12865375,low,Unclear,unclear,low,high (high and discrepant attrition),low,yes,unclear,,Unclear
Goode,12865375,2003,56.2,0,0,NA,10,10,67,67,N4+T4+T6,T2,N+T,T,tens & pfmt & biofeedback,education,1,1,cure,Goode 2003 12865375,low,Unclear,unclear,low,high (high and discrepant attrition),low,yes,unclear,,Unclear
Goode,12865375,2003,56.2,0,0,NA,11,10,66,67,T4+T6,N4+T4+T6,T,N+T,pfmt & biofeedback,tens & pfmt & biofeedback,1.14,0.877192982,cure,Goode 2003 12865375,low,Unclear,unclear,low,high (high and discrepant attrition),low,yes,unclear,,Unclear
Goode,12865375,2003,56.2,0,0,NA,53,38,66,67,T4+T6,T2,T,T,pfmt & biofeedback,education,3.111336032,0.321405335,improvement,Goode 2003 12865375,low,Unclear,unclear,low,high (high and discrepant attrition),low,yes,unclear,,Unclear
Goode,12865375,2003,56.2,0,0,NA,58,38,67,67,N4+T4+T6,T2,N+T,T,tens & pfmt & biofeedback,education,4.918128655,0.20332937,improvement,Goode 2003 12865375,low,Unclear,unclear,low,high (high and discrepant attrition),low,yes,unclear,,Unclear
Goode,12865375,2003,56.2,0,0,NA,53,58,66,67,T4+T6,N4+T4+T6,T,N+T,pfmt & biofeedback,tens & pfmt & biofeedback,0.632625995,1.580712788,improvement,Goode 2003 12865375,low,Unclear,unclear,low,high (high and discrepant attrition),low,yes,unclear,,Unclear
Aksac,12867764,2003,NA,0,stress,2,16,0,20,10,T4+T6,P1,T,P,pfmt & biofeedback,control,77,0.012987013,cure,Aksac 2003 12867764,Adequate,Unclear,,,,,,,,Not adequate
Aksac,12867764,2003,NA,0,stress,2,15,0,20,10,T4,P1,T,P,pfmt,control,59.18181818,0.016897081,cure,Aksac 2003 12867764,Adequate,Unclear,,,,,,,,Not adequate
Aksac,12867764,2003,NA,0,stress,2,16,15,20,20,T4+T6,T4,T,T,pfmt & biofeedback,pfmt,1.333333333,0.75,cure,Aksac 2003 12867764,Adequate,Unclear,,,,,,,,Not adequate
Aksac,12867764,2003,NA,0,stress,2,4,2,20,10,T4+T6,P1,T,P,pfmt & biofeedback,control,1,1,improvement,Aksac 2003 12867764,Adequate,Unclear,,,,,,,,Not adequate
Aksac,12867764,2003,NA,0,stress,2,5,2,20,10,T4,P1,T,P,pfmt,control,1.333333333,0.75,improvement,Aksac 2003 12867764,Adequate,Unclear,,,,,,,,Not adequate
Aksac,12867764,2003,NA,0,stress,2,4,5,20,20,T4+T6,T4,T,T,pfmt & biofeedback,pfmt,0.75,1.333333333,improvement,Aksac 2003 12867764,Adequate,Unclear,,,,,,,,Not adequate
Diokno,12934777,2003,60,1,0,NA,90,67,391,399,C1,C3,C,C,oxybutynin,tolterodine,1.481628403,0.674933066,cure,Diokno 2003 12934777,unclear,low,low,low,low,low,yes,low,,Unclear
Lagro-Janssen,1459383,1992,43.4,0,0,NA,40,2,54,56,T1+T4,P1,T,P,bladder training & pfmt,control,77.14285714,0.012962963,improvement,Lagro-Janssen 1992 1459383,unclear,Unclear,unclear,low,low,low,yes,low,,Unclear
Lagro-Janssen,1459383,1992,43.4,0,0,NA,10,1,54,56,T1+T4,P1,T,P,bladder training & pfmt,control,12.5,0.08,cure,Lagro-Janssen 1992 1459383,unclear,Unclear,unclear,low,low,low,yes,low,,Unclear
Spruijt,14616279,2003,NA,1,0,NA,7,4,25,12,N4,T4,N,T,tens,pfmt,0.777777778,1.285714286,improvement,Spruijt 2003 14616279,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Wang,14751349,2004,52.7,0,urge,NA,15,12,38,40,T4+T6,T4,T,T,pfmt & biofeedback,pfmt,1.52173913,0.657142857,cure,Wang 2004 14751349,low,Unclear,low,low,low,low,yes,low,,low
Wang,14751349,2004,52.7,0,urge,NA,17,12,42,40,N4,T4,N,T,tens,pfmt,1.586666667,0.630252101,cure,Wang 2004 14751349,low,Unclear,low,low,low,low,yes,low,,low
Wang,14751349,2004,52.7,0,urge,NA,15,17,38,42,T4+T6,N4,T,N,pfmt & biofeedback,tens,0.959079284,1.042666667,cure,Wang 2004 14751349,low,Unclear,low,low,low,low,yes,low,,low
Millard,14764128,2004,53,0,stress,NA,16,14,227,231,A1,P1,A,P,duloxetine,control,1.17535545,0.850806452,cure,Millard 2004 14764128,low,low,low,low,high (high attrition),"high (dissimilar rates of currently using PFMT - 5.7% in duloxetine, 12.1% in placebo, p=0.0017)",yes,high (differed between groups),,low
Millard,14764128,2004,53,0,stress,NA,167,148,227,231,A1,P1,A,P,duloxetine,control,1.560923423,0.640646418,improvement,Millard 2004 14764128,low,low,low,low,high (high attrition),"high (dissimilar rates of currently using PFMT - 5.7% in duloxetine, 12.1% in placebo, p=0.0017)",yes,high (differed between groups),,low
Diokno,14767293,2004,NA,1,0,NA,61,55,164,195,T1+T4,P1,T,P,bladder training & pfmt,control,1.507502207,0.663348946,cure,Diokno 2004 14767293,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Diokno,14767293,2004,NA,1,0,NA,92,80,164,195,T1+T4,P1,T,P,bladder training & pfmt,control,1.836805556,0.54442344,improvement,Diokno 2004 14767293,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kerrebroeck,14961887,2004,53,0,stress,NA,93,76,179,226,A1,P1,A,P,duloxetine,control,2.134332925,0.468530466,improvement,Kerrebroeck 2004 14961887,unclear,Unclear,unclear,low,low,low,yes,high (differential between groups),,Unclear
Khullar,15302476,2004,58.2,0,0,NA,116,318,253,521,P1,C3,P,C,control,tolterodine,0.540513244,1.850093426,improvement,Khullar 2004 15302476,low,low,low,low,low,low,yes,low,,low
Khullar,15302476,2004,58.2,0,0,NA,139,396,253,521,P1,C3,P,C,control,tolterodine,0.384879497,2.598215827,satisfaction,Khullar 2004 15302476,low,low,low,low,low,low,yes,low,,low
Cardozo,15339761,2004,53,0,stress,NA,17,4,55,54,A1,P1,A,P,duloxetine,control,5.592105263,0.178823529,improvement,Cardozo 2004 15339761,low,low,low,low,low,low,yes,low,,low
Bano,15378234,2005,61,0,stress,6,15,9,25,25,U6,U5,U,U,permacol,macroplastique,2.666666667,0.375,cure,Bano 2005 15378234,unclear,Unclear,unclear,low,low,unclear (no baselines given),yes,low,,Unclear
Amaro,15647885,2005,NA,0,0,NA,3,6,20,20,N4,P1,N,P,tens,control,0.411764706,2.428571429,ui,Amaro 2005 15647885,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kinchen,15662490,2005,53,0,stress,3,98,94,140,186,A1,P1,A,P,duloxetine,control,2.283687943,0.437888199,improvement,Kinchen 2005 15662490,low,low,low,low,high (high and differential attrition),low,yes,low,,unclear
But,15821527,2005,54,0,0,NA,11,3,26,13,N3,P1,N,P,magnetic stimulation,control,2.444444444,0.409090909,improvement,But 2005 15821527,low,low,low,low,low,high (baselines differ consistently in the same direction),yes,low,,low
Subak,15947625,2005,52,0,0,NA,4,14,24,24,P1,T2,P,T,control,education,0.142857143,7,improvement,Subak 2005 15947625,low,high,low,low,low,low,yes,low,,low
Waetjen,16260511,2005,NA,0,0,24,52,74,208,209,H4,P1,H,P,transdermal estrogen,control,0.608108108,1.644444444,improvement,Waetjen 2005 16260511,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Long,16412747,2006,55.3,0,0,3,3,12,37,36,H2,H1,H,H,po estrogen,vaginal estrogen,0.176470588,5.666666667,ui,Long 2006 16412747,Unclear,open-label,,,,,,,,Unclear
Yalcin,16750246,2006,51.1,0,stress,NA,198,152,433,425,A1,P1,A,P,duloxetine,control,1.513269877,0.660820661,improvement,Yalcin 2006 16750246,low,low,low,low,low,low,yes,low,,Unclear
Amaro,16752244,2006,48,0,0,NA,17,14,20,20,N4,P1,N,P,tens,control,2.428571429,0.411764706,improvement,Amaro 2006 16752244,low,low RoB,low,unclear,low,unclear (no baselines described),yes,low,,Unclear
Amaro,16752244,2006,48,0,0,NA,3,6,20,20,N4,P1,N,P,tens,control,0.411764706,2.428571429,ui,Amaro 2006 16752244,low,low RoB,low,unclear,low,unclear (no baselines described),yes,low,,Unclear
Williams,17034605,2006,56.9,0,0,NA,6,4,79,80,P1,T4,P,T,control,pfmt,1.561643836,0.640350877,cure,Williams 2006 17034605,Low,Unclear,unclear,low,low,low,yes,low,,Low
Andersen,17051030,2002,NA,0,stress,NA,3,10,21,25,U2,U4,U,U,contigen,durasphere,0.25,4,cure,Andersen 2002 17051030,unclear RoB,low RoB,low,low,low,unclear (no baselines described),yes,low,,Unclear
Andersen,17051030,2002,NA,0,stress,NA,13,20,21,25,U2,U4,U,U,contigen,durasphere,0.40625,2.461538462,improvement,Andersen 2002 17051030,unclear RoB,low RoB,low,low,low,unclear (no baselines described),yes,low,,Unclear
Steers,17511767,2007,54.6,0,0,NA,5,1,153,153,A1,P1,A,P,duloxetine,control,5.135135135,0.194736842,improvement,Steers 2007 17511767,low,low,low,low,high,low,yes,low,,Unclear
Bent,17580357,2008,53.7,0,0,NA,103,74,234,272,A1,P1,A,P,duloxetine,control,2.103775531,0.475335883,improvement,Bent 2008 17580357,low,low,high,low,high (differential attrition),low,yes,low,,Unclear
Kim,17944890,2007,76.6,1,0,NA,3,18,32,33,P1,T4,P,T,control,pfmt,0.086206897,11.6,cure,Kim 2007 17944890,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Lagro-Janssen,1807303,1991,45,0,stress,3,7,1,33,33,T4,P1,T,P,pfmt,control,8.615384615,0.116071429,cure,Lagro-Janssen 1991 1807303,unclear,Unclear,unclear,low,low,low,yes,high (67% at least good comliance),,Unclear
Lin,18221532,2008,54.4,0,stress,NA,42,28,60,61,A1,P1,A,P,duloxetine,control,2.75,0.363636364,improvement,Lin 2008 18221532,low,low,low,low,high (high attrition),"high(difference in Mean time between voids, p=0.048)",yes,high (differed between groups),,low
Brubaker,18499184,2008,0,0,0,NA,18,0,28,15,B1,P1,B,P,botox,control,54.61904762,0.018308631,improvement,Brubaker 2008 18499184,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Schagen van Leeuwena,18547757,2008,71,1,0,NA,18,14,131,134,A1,P1,A,P,duloxetine,control,1.365360303,0.732407407,improvement,Schagen van Leeuwena 2008 18547757,low,low,low,low,low,low,yes,low,,Unclear
Burgio,18678843,2008,56.9,0,urge,NA,51,31,154,153,C3+T1+T4,C3,C+T,C,tolterodine & pfmt & bladder training,tolterodine,1.948637645,0.513179042,satisfaction,Burgio 2008 18678843,low,high,high,low,low,low,yes,high (tx compliance 68%),,low
Burgio,18678843,2008,56.9,0,urge,NA,106,66,154,153,C3+T1+T4,C3,C+T,C,tolterodine & pfmt & bladder training,tolterodine,2.910984848,0.34352635,improvement,Burgio 2008 18678843,low,high,high,low,low,low,yes,high (tx compliance 68%),,low
Burgio,18678843,2008,56.9,0,urge,NA,32,26,154,153,C3+T1+T4,C3,C+T,C,tolterodine & pfmt & bladder training,tolterodine,1.281210593,0.780511811,cure,Burgio 2008 18678843,low,high,high,low,low,low,yes,high (tx compliance 68%),,low
Rogers,18685795,2008,48,0,urge,NA,89,115,211,202,P1,C3,P,C,control,tolterodine,0.55188881,1.811959189,cure,Rogers 2008 18685795,low,double-blind ,low,low (nodified ITT on >= 1 dose of study drug taken),low,low,yes,low,,Unclear
Castro,18719756,2008,54.2,0,stress,NA,13,12,30,31,N4,T4,N,T,tens,pfmt,1.210784314,0.825910931,cure,Castro 2008 18719756,low,high,low,high,low,low,yes,low,,unclear
Castro,18719756,2008,54.2,0,stress,NA,3,12,30,31,P1,T4,P,T,control,pfmt,0.175925926,5.684210526,cure,Castro 2008 18719756,low,high,low,high,low,low,yes,low,,unclear
Castro,18719756,2008,54.2,0,stress,NA,13,3,30,30,N4,P1,N,P,tens,control,6.882352941,0.145299145,cure,Castro 2008 18719756,low,high,low,high,low,low,yes,low,,unclear
Castro,18719756,2008,54.2,0,stress,NA,15,15,30,31,N4,T4,N,T,tens,pfmt,1.066666667,0.9375,satisfaction,Castro 2008 18719756,low,high,low,high,low,low,yes,low,,unclear
Castro,18719756,2008,54.2,0,stress,NA,5,15,30,31,P1,T4,P,T,control,pfmt,0.213333333,4.6875,satisfaction,Castro 2008 18719756,low,high,low,high,low,low,yes,low,,unclear
Castro,18719756,2008,54.2,0,stress,NA,15,5,30,30,N4,P1,N,P,tens,control,5,0.2,satisfaction,Castro 2008 18719756,low,high,low,high,low,low,yes,low,,unclear
Kumari,18755458,2008,44.7,0,0,NA,41,11,78,86,T1+T4,P1,T,P,bladder training & pfmt,control,7.555282555,0.132357724,ui,Kumari 2008 18755458,low,high,high,high (as treated analysis),high (high and differential attrition),low,yes,unclear,,low
Ghoniem,19013613,2009,61,0,stress,NA,25,34,94,102,P1,U5,P,U,control,macroplastique,0.724637681,1.38,cure,Ghoniem 2009 19013613,low,low,low,low,high (>20% attrition),low,yes,low,,low
Ghoniem,19013613,2009,61,0,stress,NA,60,75,125,122,P1,U5,P,U,control,macroplastique,0.578461538,1.728723404,improvement,Ghoniem 2009 19013613,low,low,low,low,high (>20% attrition),low,yes,low,,low
Rogers,19601704,2009,48,0,0,NA,101,143,211,202,P1,C3,P,C,control,tolterodine,0.378830261,2.639704648,satisfaction,Rogers 2009 19601704,unclear,low,low,low,Unclear RoB (no information reported),low,yes,unclear (not described),,unclear
Peters,19616802,2009,58,0,urge,NA,35,23,44,42,N1,C3,N,C,electroacupuncture,tolterodine,3.212560386,0.311278195,cure,Peters 2009 19616802,low,open-label,low,unclear,low,low,yes,low,,unclear
Peters,19616802,2009,58,0,urge,NA,34,21,44,42,N1,C3,N,C,electroacupuncture,tolterodine,3.4,0.294117647,improvement,Peters 2009 19616802,low,open-label,low,unclear,low,low,yes,low,,unclear
Peters,19616802,2009,58,0,urge,NA,24,27,30,37,N1,C3,N,C,electroacupuncture,tolterodine,1.481481481,0.675,ui,Peters 2009 19616802,low,open-label,low,unclear,low,low,yes,low,,unclear
Lightner,19660800,2009,56.1,0,stress,NA,74,93,88,143,U2,U7,U,U,contigen,zuidex,2.841781874,0.351891892,improvement,Lightner 2009 19660800,Unclear,Unclear,Unclear,low,high (high attrition),low,yes,high,,Unclear
Sand,19727537,2009,58,0,0,NA,103,163,505,484,P1,C4,P,C,control,trospium,0.504578335,1.981852826,cure,Sand 2009 19727537,low,low,low,low,low,low,yes,low,,Unclear
Lamb,19751517,2009,51.3,0,0,NA,47,66,63,111,T5+T4,T1+T4,T,T,bladder support & pfmt,bladder training & pfmt,2.002840909,0.49929078,improvement,Lamb 2009 19751517,Low,Unclear,Low,Low,Low,Low,yes,Low,,High
Fantl,1987410,1991,67,0,0,1.5,49,16,65,66,T1,P1,T,P,bladder training,control,9.5703125,0.104489796,improvement,Fantl 1991 1987410,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Fantl,1987410,1991,67,0,0,1.5,8,2,65,66,T1,P1,T,P,bladder training,control,4.49122807,0.22265625,cure,Fantl 1991 1987410,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Cardozo,19929591,2010,55,0,stress,NA,876,669,1378,1380,A1,P1,A,P,duloxetine,control,1.85457274,0.539207753,improvement,Cardozo 2010 19929591,low,low,low,low,low,low,yes,low,,low
Thüroff,2005707,1991,50,0,urge,NA,35,20,126,104,C1,P1,C,P,oxybutynin,control,1.615384615,0.619047619,improvement,Thüroff 1991 2005707,low,low,low,low,low,low,yes,low,,low
Richter,20177294,2010,49.8,0,0,NA,54,52,146,151,T4,T5+T4,T,T,pfmt,bladder support & pfmt,1.117474916,0.894874673,improvement,Richter 2010 20177294,Adequate,open-label,low,low,low,low,yes,low,,Not adequate
Richter,20177294,2010,49.8,0,0,NA,51,52,149,151,T5,T5+T4,T,T,bladder support,bladder support & pfmt,0.99077708,1.009308774,improvement,Richter 2010 20177294,Adequate,open-label,low,low,low,low,yes,low,,Not adequate
Richter,20177294,2010,49.8,0,0,NA,54,51,146,149,T4,T5,T,T,pfmt,bladder support,1.127877238,0.886621315,improvement,Richter 2010 20177294,Adequate,open-label,low,low,low,low,yes,low,,Not adequate
Richter,20177294,2010,49.8,0,0,NA,59,49,146,151,T4,T5+T4,T,T,pfmt,bladder support & pfmt,1.411681914,0.708374875,cure,Richter 2010 20177294,Adequate,open-label,low,low,low,low,yes,low,,Not adequate
Richter,20177294,2010,49.8,0,0,NA,52,49,149,151,T5,T5+T4,T,T,bladder support,bladder support & pfmt,1.115926783,0.896116139,cure,Richter 2010 20177294,Adequate,open-label,low,low,low,low,yes,low,,Not adequate
Richter,20177294,2010,49.8,0,0,NA,59,52,146,149,T4,T5,T,T,pfmt,bladder support,1.265030946,0.790494496,cure,Richter 2010 20177294,Adequate,open-label,low,low,low,low,yes,low,,Not adequate
Richter,20177294,2010,49.8,0,0,NA,79,81,146,151,T4,T5+T4,T,T,pfmt,bladder support & pfmt,1.018979178,0.981374322,satisfaction,Richter 2010 20177294,Adequate,open-label,low,low,low,low,yes,low,,Not adequate
Richter,20177294,2010,49.8,0,0,NA,75,81,149,151,T5,T5+T4,T,T,bladder support,bladder support & pfmt,0.875875876,1.141714286,satisfaction,Richter 2010 20177294,Adequate,open-label,low,low,low,low,yes,low,,Not adequate
Richter,20177294,2010,49.8,0,0,NA,79,75,146,149,T4,T5,T,T,pfmt,bladder support,1.163383085,0.859562094,satisfaction,Richter 2010 20177294,Adequate,open-label,low,low,low,low,yes,low,,Not adequate
Hung,20185357,2010,48.8,0,0,NA,1,5,35,35,P1,T4,P,T,control,pfmt,0.176470588,5.666666667,cure,Hung 2010 20185357,low,Unclear,unclear,low,low,low,yes,low,,low
Hung,20185357,2010,48.8,0,0,NA,23,34,35,35,P1,T4,P,T,control,pfmt,0.056372549,17.73913043,improvement,Hung 2010 20185357,low,Unclear,unclear,low,low,low,yes,low,,low
Schreiner,20458465,2010,68.3,1,0,NA,9,18,26,26,T1,N4+T1,T,N+T,bladder training,bladder training & tens,0.235294118,4.25,cure,Schreiner 2010 20458465,low,Unclear,unclear,unclear,low,low,yes,unclear (not described),,Unclear
Burgio,20639023,2010,58.4,0,urge,NA,28,25,32,32,C1,C1+T4,C,C+T,oxybutynin,oxybutynin & pfmt,1.96,0.510204082,satisfaction,Burgio 2010 20639023,low,high,high,low,low,low,yes,low,,Unclear
Burgio,20639023,2010,58.4,0,urge,NA,29,25,32,32,C1,C1+T4,C,C+T,oxybutynin,oxybutynin & pfmt,2.706666667,0.369458128,improvement,Burgio 2010 20639023,low,high,high,low,low,low,yes,low,,Unclear
Wells,2071809,1991,66,1,0,6,22,11,82,75,T4,C7,T,C,pfmt,phenylpropanolamine,2.133333333,0.46875,cure,Wells 1991 2071809,Low,Unclear,unclear,low,low,low,yes,low,,Unclear
Wells,2071809,1991,66,1,0,6,17,29,82,75,T4,C7,T,C,pfmt,phenylpropanolamine,0.414854111,2.410485934,improvement,Wells 1991 2071809,Low,Unclear,unclear,low,low,low,yes,low,,Unclear
Ahlstrom,2227611,1990,NA,1,stress,NA,0,0,29,29,H2,C7+H2,H,C+H,po estrogen,po estrogen & phenylpropanolamine,1,1,cure,Ahlstrom 1990 2227611,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Ahlstrom,2227611,1990,NA,1,stress,NA,11,13,29,29,H2,C7+H2,H,C+H,po estrogen,po estrogen & phenylpropanolamine,0.752136752,1.329545455,improvement,Ahlstrom 1990 2227611,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Moore,2249115,1990,46,0,urge,NA,10,1,28,25,C1,P1,C,P,oxybutynin,control,13.33333333,0.075,improvement,Moore 1990 2249115,low,low,low,unclear,high (high attrition due to side effects),low,yes,high (differed between groups),,low
Moore,2249115,1990,46,0,urge,NA,5,0,28,25,C1,P1,C,P,oxybutynin,control,11.93617021,0.083778966,cure,Moore 1990 2249115,low,low,low,unclear,high (high attrition due to side effects),low,yes,high (differed between groups),,low
Harvey,318,2002,47.2,0,0,NA,2,2,19,25,T4+T6,T4+T9,T,T,pfmt & biofeedback,pfmt & weights,1.352941176,0.739130435,cure,Harvey 2002 318,Adequate,Unclear,,,,,,,,Unclear
Shepherd,6611720,1983,48,0,stress,NA,10,6,11,11,T4+T6,T4,T,T,pfmt & biofeedback,pfmt,8.333333333,0.12,improvement,Shepherd 1983 6611720,Unclear,high,high,low,low,low,yes,low,,unclear
Shepherd,6611720,1983,48,0,stress,NA,8,3,11,11,T4+T6,T4,T,T,pfmt & biofeedback,pfmt,7.111111111,0.140625,cure,Shepherd 1983 6611720,Unclear,high,high,low,low,low,yes,low,,unclear
Szonyi G,7484484,1995,82,1,urge,NA,1,0,28,29,C1,P1,C,P,oxybutynin,control,3.218181818,0.310734463,cure,Szonyi G 1995 7484484,low,low,low,low,low,low,yes,low,,unclear
Szonyi G,7484484,1995,82,1,urge,NA,22,16,28,29,C1,P1,C,P,oxybutynin,control,2.979166667,0.335664336,improvement,Szonyi G 1995 7484484,low,low,low,low,low,low,yes,low,,unclear
Smith,7490809,1996,NA,0,0,NA,2,1,9,9,N4,T4,N,T,tens,pfmt,2.285714286,0.4375,cure,Smith 1996 7490809,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Smith,7490809,1996,NA,0,0,NA,4,3,9,9,N4,T4,N,T,tens,pfmt,1.6,0.625,improvement,Smith 1996 7490809,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Smith_a,7490809_a,1996,NA,0,0,NA,3,4,18,20,C8,N4,C,N,propantheline,tens,0.8,1.25,cure,Smith_a 1996 7490809_a,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Smith_a,7490809_a,1996,NA,0,0,NA,10,13,18,20,C8,N4,C,N,propantheline,tens,0.673076923,1.485714286,improvement,Smith_a 1996 7490809_a,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Sand,7631730,1995,53.2,0,stress,NA,7,2,35,17,N4,P1,N,P,tens,control,1.875,0.533333333,cure,Sand 1995 7631730,low,low,low,low,low,High (age differed between interventions),yes,low,,Unclear
Sand,7631730,1995,53.2,0,stress,NA,16,3,35,17,N4,P1,N,P,tens,control,3.929824561,0.254464286,improvement,Sand 1995 7631730,low,low,low,low,low,High (age differed between interventions),yes,low,,Unclear
Burns,8315230,1993,62,1,0,6,9,1,40,39,T4+T6,P1,T,P,pfmt & biofeedback,control,11.03225806,0.090643275,cure,Burns 1993 8315230,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Burns,8315230,1993,62,1,0,6,7,1,43,39,T4,P1,T,P,pfmt,control,7.388888889,0.135338346,cure,Burns 1993 8315230,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Burns,8315230,1993,62,1,0,6,9,7,40,43,T4+T6,T4,T,T,pfmt & biofeedback,pfmt,1.493087558,0.669753086,cure,Burns 1993 8315230,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Burns,8315230,1993,62,1,0,6,24,2,40,39,T4+T6,P1,T,P,pfmt & biofeedback,control,27.75,0.036036036,improvement,Burns 1993 8315230,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Burns,8315230,1993,62,1,0,6,23,2,43,39,T4,P1,T,P,pfmt,control,21.275,0.047003525,improvement,Burns 1993 8315230,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Burns,8315230,1993,62,1,0,6,24,23,40,43,T4+T6,T4,T,T,pfmt & biofeedback,pfmt,1.304347826,0.766666667,improvement,Burns 1993 8315230,low,Unclear,unclear,low,low,low,yes,low,,Unclear
Berghmans,8696355,1996,48.4,0,stress,3,3,5,20,20,T4,T4+T6,T,T,pfmt,pfmt & biofeedback,0.529411765,1.888888889,cure,Berghmans 1996 8696355,low,high,high,low,low,low,yes,low,,low
Berghmans,8696355,1996,48.4,0,stress,3,14,14,20,20,T4,T4+T6,T,T,pfmt,pfmt & biofeedback,1,1,improvement,Berghmans 1996 8696355,low,high,high,low,low,low,yes,low,,low
Glavind,9203484,1996,45,0,stress,NA,0,5,15,19,T4,T4+T6,T,T,pfmt,pfmt & biofeedback,0.085043988,11.75862069,cure,Glavind 1996 9203484,low,Unclear,unclear,low,low,low,yes,low,,low
Glavind,9203484,1996,45,0,stress,NA,4,8,15,19,T4,T4+T6,T,T,pfmt,pfmt & biofeedback,0.5,2,improvement,Glavind 1996 9203484,low,Unclear,unclear,low,low,low,yes,low,,low
Brubaker,9322620,1997,NA,0,0,NA,10,21,61,60,P1,N4,P,N,control,tens,0.364145658,2.746153846,improvement,Brubaker 1997 9322620,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Luber,9353803,1997,53.9,0,stress,NA,2,4,20,24,N4,P1,N,P,tens,control,0.555555556,1.8,cure,Luber 1997 9353803,low,low,low,unclear,high,low,yes,unclear (not described),,low
Luber,9353803,1997,53.9,0,stress,NA,3,3,20,24,N4,P1,N,P,tens,control,1.235294118,0.80952381,improvement,Luber 1997 9353803,low,low,low,unclear,high,low,yes,unclear (not described),,low
Holtedahl,9688247,1998,61,1,0,6,8,0,36,44,H1+N4+T4,P1,H+N+T,P,vaginal estrogen & tens & pfmt,control,26.54385965,0.037673496,cure,Holtedahl 1998 9688247,low,high,high,low,low,low,yes,low,,low
Holtedahl,9688247,1998,61,1,0,6,14,4,36,44,H1+N4+T4,P1,H+N+T,P,vaginal estrogen & tens & pfmt,control,6.363636364,0.157142857,improvement,Holtedahl 1998 9688247,low,high,high,low,low,low,yes,low,,low
Wyman,9790388,1998,61,0,0,NA,16,13,67,69,T1+T4+T6,T4+T6,T,T,bladder training & pfmt & biofeedback,pfmt & biofeedback,1.351432881,0.739955357,cure,Wyman 1998 9790388,Unclear,Unclear,unclear,low,low,low,yes,high (differed between groups),,Unclear
Wyman,9790388,1998,61,0,0,NA,10,13,68,69,T1,T4+T6,T,T,bladder training,pfmt & biofeedback,0.74270557,1.346428571,cure,Wyman 1998 9790388,Unclear,Unclear,unclear,low,low,low,yes,high (differed between groups),,Unclear
Wyman,9790388,1998,61,0,0,NA,16,10,67,68,T1+T4+T6,T1,T,T,bladder training & pfmt & biofeedback,bladder training,1.819607843,0.549568966,cure,Wyman 1998 9790388,Unclear,Unclear,unclear,low,low,low,yes,high (differed between groups),,Unclear
Wyman,9790388,1998,61,0,0,NA,45,42,67,69,T1+T4+T6,T4+T6,T,T,bladder training & pfmt & biofeedback,pfmt & biofeedback,1.314935065,0.760493827,satisfaction,Wyman 1998 9790388,Unclear,Unclear,unclear,low,low,low,yes,high (differed between groups),,Unclear
Wyman,9790388,1998,61,0,0,NA,36,42,68,69,T1,T4+T6,T,T,bladder training,pfmt & biofeedback,0.723214286,1.382716049,satisfaction,Wyman 1998 9790388,Unclear,Unclear,unclear,low,low,low,yes,high (differed between groups),,Unclear
Wyman,9790388,1998,61,0,0,NA,45,36,67,68,T1+T4+T6,T1,T,T,bladder training & pfmt & biofeedback,bladder training,1.818181818,0.55,satisfaction,Wyman 1998 9790388,Unclear,Unclear,unclear,low,low,low,yes,high (differed between groups),,Unclear
Wyman,9790388,1998,61,0,0,NA,31,24,67,69,T1+T4+T6,T4+T6,T,T,bladder training & pfmt & biofeedback,pfmt & biofeedback,1.614583333,0.619354839,improvement,Wyman 1998 9790388,Unclear,Unclear,unclear,low,low,low,yes,high (differed between groups),,Unclear
Wyman,9790388,1998,61,0,0,NA,21,24,68,69,T1,T4+T6,T,T,bladder training,pfmt & biofeedback,0.837765957,1.193650794,improvement,Wyman 1998 9790388,Unclear,Unclear,unclear,low,low,low,yes,high (differed between groups),,Unclear
Wyman,9790388,1998,61,0,0,NA,31,21,67,68,T1+T4+T6,T1,T,T,bladder training & pfmt & biofeedback,bladder training,1.927248677,0.518874399,improvement,Wyman 1998 9790388,Unclear,Unclear,unclear,low,low,low,yes,high (differed between groups),,Unclear
Burgio,9863850,1998,NA,1,urge,NA,19,8,65,65,T4+T6,P1,T,P,pfmt & biofeedback,control,2.942934783,0.339796861,cure,Burgio 1998 9863850,low,low,low,low,low,"high (subjects in behavior gorup had more children, less likely to have HS education, more likely to have rectocele)",yes,low,,Unclear
Burgio,9863850,1998,NA,1,urge,NA,15,8,67,65,C1,P1,C,P,oxybutynin,control,2.055288462,0.486549708,cure,Burgio 1998 9863850,low,low,low,low,low,"high (subjects in behavior gorup had more children, less likely to have HS education, more likely to have rectocele)",yes,low,,Unclear
Burgio,9863850,1998,NA,1,urge,NA,19,15,65,67,T4+T6,C1,T,C,pfmt & biofeedback,oxybutynin,1.431884058,0.698380567,cure,Burgio 1998 9863850,low,low,low,low,low,"high (subjects in behavior gorup had more children, less likely to have HS education, more likely to have rectocele)",yes,low,,Unclear
Burgio,9863850,1998,NA,1,urge,NA,45,14,65,65,T4+T6,P1,T,P,pfmt & biofeedback,control,8.196428571,0.122004357,satisfaction,Burgio 1998 9863850,low,low,low,low,low,"high (subjects in behavior gorup had more children, less likely to have HS education, more likely to have rectocele)",yes,low,,Unclear
Burgio,9863850,1998,NA,1,urge,NA,27,14,67,65,C1,P1,C,P,oxybutynin,control,2.458928571,0.406681191,satisfaction,Burgio 1998 9863850,low,low,low,low,low,"high (subjects in behavior gorup had more children, less likely to have HS education, more likely to have rectocele)",yes,low,,Unclear
Burgio,9863850,1998,NA,1,urge,NA,45,27,65,67,T4+T6,C1,T,C,pfmt & biofeedback,oxybutynin,3.333333333,0.3,satisfaction,Burgio 1998 9863850,low,low,low,low,low,"high (subjects in behavior gorup had more children, less likely to have HS education, more likely to have rectocele)",yes,low,,Unclear
Burgio,9863850,1998,NA,1,urge,NA,58,34,65,65,T4+T6,P1,T,P,pfmt & biofeedback,control,7.554621849,0.132369299,improvement,Burgio 1998 9863850,low,low,low,low,low,"high (subjects in behavior gorup had more children, less likely to have HS education, more likely to have rectocele)",yes,low,,Unclear
Burgio,9863850,1998,NA,1,urge,NA,45,34,67,65,C1,P1,C,P,oxybutynin,control,1.864973262,0.536200717,improvement,Burgio 1998 9863850,low,low,low,low,low,"high (subjects in behavior gorup had more children, less likely to have HS education, more likely to have rectocele)",yes,low,,Unclear
Burgio,9863850,1998,NA,1,urge,NA,58,45,65,67,T4+T6,C1,T,C,pfmt & biofeedback,oxybutynin,4.050793651,0.246865204,improvement,Burgio 1998 9863850,low,low,low,low,low,"high (subjects in behavior gorup had more children, less likely to have HS education, more likely to have rectocele)",yes,low,,Unclear
Tejero,no pmid,2008,NA,0,stress,NA,10,12,16,18,T4+T6,T4,T,T,pfmt & biofeedback,pfmt,0.833333333,1.2,improvement,Tejero 2008 no pmid,high,high,unclear,high,high,low,yes,low,,high